DSFCL
DCM Shriram Fine Chemicals Limited
NSEFiling History
Recent corporate announcements and filings for DSFCL
Routine
Neutral
2026-07-14 21:16
New Filing detected. See link for details.
Routine
Neutral
2026-07-14 21:08
New Filing detected. See link for details.
Routine
Neutral
2026-07-14 21:05
New Filing detected. See link for details.
Routine
Neutral
2026-07-14 18:34
New Filing detected. See link for details.
Governance
Neutral
2026-07-14 18:30
- Board of Directors meeting held on July 14, 2026.
- Mr. Nitin Atroley appointed as an Additional Director (Non-Executive Independent Director) for 5 years, effective July 15, 2026.
- Mr. Alok Bansidhar Shriram appointed as Non-Executive Non-Independent Director and Chairman of the Board for 1 year, effective July 15, 2026.
Governance
Positive
2026-07-14 18:30
- Board meeting held on July 14, 2026.
- Appointed Mr. Nitin Atroley as an Additional Director (Non-Executive Independent Director) for a period of 5 years, effective July 15, 2026.
- Appointed Mr. Alok Bansidhar Shriram as Non-Executive Non-Independent Director and Chairman of the Board for a period of one year, effective July 15, 2026.
Routine
Neutral
2026-06-25 18:20
- Trading Window for DCM Shriram Fine Chemicals Limited equity shares closes from July 1, 2026. It will remain closed until 48 hours after the declaration of Un-audited Financial Results for the quarter ending June 30, 2026. The Board Meeting date for considering these results will be intimated later.
Governance
Positive
2026-06-23 22:34
- DCM Shriram Fine Chemicals Ltd. dispatched the Annual Report and Notice for the 5th Annual General Meeting (AGM) for FY 2025-26.
- The AGM is scheduled for Tuesday, 14th July, 2026, at 11:30 A.M. (IST) via Video Conferencing/OAVM.
- A dividend of ₹0.40 per equity share (20% of face value) for FY 2025-26 was declared.
- The record date for the final dividend and cut-off date for e-voting entitlement is Wednesday, 01st July, 2026.
Financials
Positive
2026-06-20 20:43
- Board recommended a maiden final dividend of ₹0.40 (20%) per equity share for FY 2025-26, subject to shareholder approval at the AGM.
- The 5th Annual General Meeting (AGM) is scheduled for July 14, 2026, at 11:30 A.M. IST via video conferencing.
- Detailed instructions for tax deduction at source (TDS) on the dividend for resident and non-resident shareholders were provided, with a record date of July 1, 2026.
Governance
Positive
2026-06-20 19:39
- The 5th Annual General Meeting (AGM) will be held on Tuesday, 14th July, 2026 at 11:30 AM (IST) via Video Conferencing/OAVM.
- The Board recommended a dividend of ₹0.40 per equity share for FY 2025-26.
- The Record Date for dividend is Wednesday, 1st July, 2026.
- Share Transfer Books will be closed from 3rd July to 14th July, 2026 (both days inclusive).
Governance
Neutral
2026-06-20 19:36
- The 5th AGM is scheduled for Tuesday, 14th July, 2026, at 11:30 AM (IST) via VC/OAVM.
- A dividend of ₹0.40 per equity share for FY 2025-26 has been recommended.
- The Record Date for dividend and e-voting cut-off is Wednesday, 1st July, 2026.
- Agenda includes director re-appointments and proposed alterations to the Articles of Association.
Governance
Negative
2026-05-28 17:44
CRITICAL RED FLAG DETECTED
DCM Shriram Fine Chemicals Ltd. received notices from BSE and NSE imposing a fine of Rs. 68,440/- each (total Rs. 1,36,880/-) for technical non-compliance with SEBI (LODR) Regulation 17(1A). The non-compliance relates to a delay in obtaining prior shareholder approval for the appointment/continuation of Non-Executive Director Mr. Sunil Behari Mathur, who is over 75. The company stated it was an unintended omission and has initiated a postal ballot for approval, confirming the financial impact is limited to the fine.
Financials
Negative
2026-05-19 18:38
Consolidated Revenue ₹9,248 Lakhs vs ₹9,601 Lakhs (▼3.7% YoY), EBITDA ₹-251 Lakhs vs ₹32 Lakhs (▼884.4% YoY), PAT ₹-383 Lakhs vs ₹-149 Lakhs (▲157.1% YoY). EBITDA Margin -2.7% vs 0.3% (▼304bps).
Financials
Negative
2026-05-19 18:23
Consolidated Operating Revenue ₹93.08 Cr vs ₹96.92 Cr (▼4.0% YoY). EBITDA swung from ₹0.32 Cr (profit) to ₹(2.51) Cr (loss) YoY. PAT loss widened from ₹(1.49) Cr to ₹(3.83) Cr YoY. EBITDA Margin contracted from 0.33% to -2.69% YoY. The Board also recommended a dividend of ₹0.40 per equity share for FY 2025-26.
Financials
Negative
2026-05-19 17:34
Consolidated Revenue ₹9,308 Lakhs vs ₹9,695 Lakhs (▼4% YoY), EBITDA turned to a loss of ₹(251) Lakhs from a profit of ₹32 Lakhs YoY, PAT loss increased to ₹(383) Lakhs from ₹(149) Lakhs YoY. EBITDA Margin contracted from 0.33% to -2.70%. The Board also recommended a dividend of ₹0.40 per equity share for FY2025-26.
Routine
Neutral
2026-04-14 14:38
DCM Shriram Fine Chemicals Ltd. corrected an error in its April 8, 2026 letter on credit rating, stating the SEBI regulation reference was incorrect. It should have referred to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, instead of (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Routine
Neutral
2026-04-14 13:19
DCM Shriram Fine Chemicals Ltd. submitted certificates under SEBI Regulation 74(5) from KFIN Technologies Limited for the quarter ended March 31, 2026, confirming compliance regarding dematerialized/rematerialized securities.
Routine
Neutral
2026-04-08 18:35
New Filing detected. See link for details.